Carpal tunnel syndrome associated with the use of aromatase inhibitors in breast cancer

Clinical Breast Cancer

Volumn 8, Issue 4, 2008, Pages 362-365

  Nishihori, Taiga ^a   Choi, Jaehyuk ^a   DiGiovanna, Michael P ^a   Thomson, J Grant ^b   Kohler, Peter C ^c   McGurn, Joanne ^d   Chung, Gina G ^a  

^a YALE CANCER CENTER   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Traverse Area Hematology/Oncology   (United States)

^d MUNSON MEDICAL CENTER   (United States)

Author keywords

Adjuvant therapy; Estrogen receptor; Paresthesia; Sentinel lymph node dissection

Indexed keywords

ANASTROZOLE; AROMATASE INHIBITOR; CYCLOPHOSPHAMIDE; DOCETAXEL; DOXORUBICIN; FLUOROURACIL; LETROZOLE; METHOTREXATE; PACLITAXEL; TAMOXIFEN;

ADULT; AGED; ARTHRALGIA; ARTICLE; BREAST CANCER; CANCER ADJUVANT THERAPY; CARPAL TUNNEL SYNDROME; CLINICAL ARTICLE; CONSERVATIVE TREATMENT; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; HUMAN; INCIDENCE; JOINT STIFFNESS; LIMB PAIN; MASTECTOMY; MONONEUROPATHY; MYALGIA; NEUROPATHIC PAIN; PARESTHESIA; PARTIAL MASTECTOMY; SYMPTOMATOLOGY;

EID: 53449090907     PISSN: 15268209     EISSN: None     Source Type: Journal    
DOI: 10.3816/CBC.2008.n.043     Document Type: Article

References (26)

1. O'Regan RM, Jordan VC. The evolution of tamoxifen therapy in breast cancer:. selective oestrogen-receptor modulators and downregulators. Lancet Oncol 2002; 3:207-14.
2. Buzdar AU, Robertson JF, Eiermann W, et al. An overview of the pharmacology and pharmacokinetics of the newer generation aromatase inhibitors anastrozole, letrozole, and exemestane. Cancer 2002; 95:2006-16.
3. Nabholtz JM, Buzdar A, Pollak M, et al. Anastrozole is superior to tamoxifen as first-line therapy for advanced breast cancer in postmenopausal women: results of a North American multicenter randomized trial. Arimidex Study Group. J Clin Oncol 2000; 18:3758-67.
4. Baum M, Budzar AU, Cuzick J, et al. Anasrtozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early breast cancer: first results of the ATAC tandomised trial. Lancet 2002; 359:2131-9.
5. Goss PE, Ingle JN, Martino S, et al. A randomized trial of letrozole in postmenopausal women after five years of tamoxifen therapy for early-stage breast cancer. N Engl J Med 2003; 349:1793-802.
6. Winer EP, Hudis C, Burstein HJ, et al. American Society of Clinical Oncology technology assessment on the use of aromatase inhibitors as adjuvant therapy for postmenopausal women with hormone receptor-positive breast cancer:, status report 2004. J Clin Oncol 2005; 23:619-29.
7. Pandya N, Morris GJ. Toxicity of aromatase inhibitors. Semin Oncol 2006; 33:688-95.
8. Bursrein HJ. Aromatase inhibitor-aasociated arthralgia syndrome. Breast 2007; 16:233-34.
9. Mollman JE. Cisplatin neurotoxicity. N Engl J Med 1990; 322:126-7.
10. Rowinsky EK, Eisenhauer EA, Chaudhry V, et al. Clinical toxicities encountered with paclitaxel (Taxol). Semin Oncol 1993; 20:1-15.
11. Dellon AL, Swier P, Maloney CT, Jr, et al. Chemotherapy-induced neuropathy: treatment by decompression of peripheral nerves. Plast Reconstr Surg 2004; 114:478-83.
12. Dawson WJ, Elenz DR, Winchester DP, et al Elective hand surgery in the breast cancer patient with prior ipsilateral axillary dissection. Ann Surg Oncol 1995; 2:132-7.
13. Ganel A, Engel J, Sela M, et al. Nerve entrapments associated with postmastectomy lymphedema. Cancer 1979; 44:2254-9.
14. Burns RJ. Delayed radiation-induced damage to the brachial plexus. Clin Exp Neurol 1978; 15:221-7.
15. Fillingim RB, Ness TJ. Sex-related hormonal influences on pain and analgesic responses. Neurosci Biobehav Rev 2000; 24:485-501.
16. Foekens JA, Peters HA, Grebenchtchikov N, et al. High tumor levels of vascular endothelial growth factor predict poor response to systemic therapy in advanced breast cancer. Cancer Res 2001; 61:5407-14.
17. D'Agostino P, Milano S, Barbera C, et al. Sex hormones modulate inflammatory mediators produced by macrophages. Ann N Y Acad Sci 1999; 876:426-9.
18. Friedman AJ, Juneau-Norcross M, Rein MS. Adverse effects of leuprolide acetate depot treatment. Fertil Steril 1993; 59:448-50.
19. Greendale GA, Reboussin BA, Hogan P, et al. Symptom relief and side effects of postmenopausal hormones: results from the Postmenopausal Estrogen/Progestin Interventions Trial. Obstet Gynecol 1998; 92:982-8.
20. Ho SC, Chan SG, Yip YB, et al. Menopausal symptoms and symptom clustering in Chinese women. Maturitas 1999; 33:219-27.
21. Atroshi I, Gummesson C, Johnsson R. et al. Prevalence of carpal tunnel syndrome in a general population. JAMA 1999; 282:153-8.
22. Pascual E, Giner V, Arostegui A, et al. Higher incidence of carpal tunnel syndrome in oophorectomized women. Br J Rheumatol 1991; 30:60-2.
23. Crew KD, Apollo A, Greenlee H, et al. Prevalence of joint symptoms in postmenopausal women on aromatase inhibitors for early stage breast cancer. Breast Cancer Res Treat 2006; 100(suppl 1):s235 (Abstract 5068).
24. Salgado B, Zivian MT. Aromatase inhibitors: side effects reported by 612 women. Breast Cancer Res Treat 2006; 100(suppl 1):S168 (Abstract 3131).
25. Morales L, Pans S, Paridaens R, et al. Debilitating muskuloskeletal pain and stiffness with letrozole and exemestane: associated tenosynovial changes on magnetic resonance imaging. Breast Cancer Res Treat 2006; 100(suppl 1):S190 (Abstract 4056).
26. Azria D, Lamy PJ, Belkacemi Y, et al. Letrozole-induced arthralgia is not consistent with an autoimmune disease resembling Sjogren's syndrome: Preliminary results of a multicentric prospective trial. Breast Cancer Res Treat 2006; 100(suppl 1):S25 (Abstract 106).